The updated delivery system maintains the core effectiveness of the original TRAUMAGEL, a hydrogel that stops moderate to severe bleeding in seconds without requiring prior preparation. By shrinking the form factor, Cresilon aims to address the space constraints inherent in tactical and emergency medical kits. The company confirmed that the original, larger-format version will remain available alongside this new iteration.

Clinical data continues to validate the technology, with peer-reviewed reports highlighting its success in complex injury scenarios where traditional methods failed. In some cases, responders have utilized the gel to maintain hemostasis after removing tourniquets, reducing the risk of rebleeding during transport. CEO Joe Landolina emphasized that the design changes prioritize deployment speed, ensuring that the critical seconds saved in the field translate into better outcomes for trauma patients.

Cresilon is presenting the new technology at the EMS World Expo 2026 in Orlando, Florida, through October 1. Attendees can view demonstrations of the device at booth #1321, where company representatives are detailing its application in emergency and trauma care settings.